Pacific Biosciences of California, Inc.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
Asset Breakdown FY2017
Total Assets: $144.1M
Liabilities Breakdown FY2017
Total Liabilities: $58.0M
Asset Breakdown
Total Assets: $144.1M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $16.5M | 11.5% |
| Accounts Receivable | $13.4M | 9.3% |
| Inventory | $23.1M | 16.0% |
| Property, Plant & Equipment | $37.9M | 26.3% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $53.2M | 36.9% |
Liabilities Breakdown
Total Liabilities: $58.0M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $9.1M | 15.7% |
| Long-Term Debt | $13.6M | 23.5% |
| Other Liabilities | $35.3M | 60.8% |